Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Central nervous system complications in adult cystinosis patients.

Servais A, Saitovitch A, Hummel A, Boisgontier J, Scemla A, Sberro-Soussan R, Snanoudj R, Lemaitre H, Legendre C, Pontoizeau C, Antignac C, Anglicheau D, Funalot B, Boddaert N.

J Inherit Metab Dis. 2019 Aug 24. doi: 10.1002/jimd.12164. [Epub ahead of print]

PMID:
31444911
2.

Epitope load identifies kidney transplant recipients at risk of allosensitization following minimization of immunosuppression.

Snanoudj R, Kamar N, Cassuto E, Caillard S, Metzger M, Merville P, Thierry A, Jollet I, Grimbert P, Anglicheau D, Hazzan M, Choukroun G, Hurault De Ligny B, Janbon B, Vuiblet V, Devys A, Le Meur Y, Delahousse M, Morelon E, Bailly E, Girerd S, Amokrane K, Legendre C, Hertig A, Rondeau E, Taupin JL.

Kidney Int. 2019 Jun;95(6):1471-1485. doi: 10.1016/j.kint.2018.12.029. Epub 2019 Mar 5.

PMID:
30955869
3.

Conversion from calcineurin inhibitors to belatacept in HLA- sensitized kidney-transplant recipients with low-level donor specific antibodies.

Ulloa CE, Anglicheau D, Snanoudj R, Scemla A, Martinez F, Timsit MO, Legendre C, Sberro-Soussan R.

Transplantation. 2019 Jan 30. doi: 10.1097/TP.0000000000002592. [Epub ahead of print]

PMID:
30720681
4.

Baseline graft status is a critical predictor of kidney graft failure after diarrhoea.

Devresse A, Morin L, Aulagnon F, Taupin JL, Scemla A, Lanternier F, Aubert O, Aidoud AA, Lebreton X, Sberro-Soussan R, Snanoudj R, Amrouche L, Tinel C, Martinez F, Bererhi L, Anglicheau D, Lortholary O, Legendre C, Avettand-Fenoel V, Zuber J.

Nephrol Dial Transplant. 2019 Sep 1;34(9):1597-1604. doi: 10.1093/ndt/gfy386.

PMID:
30608553
5.

No clinical benefit of rapid versus gradual tapering of immunosuppression to treat sustained BK virus viremia after kidney transplantation: a single-center experience.

Devresse A, Tinel C, Vermorel A, Snanoudj R, Morin L, Avettand-Fenoel V, Amrouche L, Scemla A, Zuber J, Legendre C, Rabant M, Anglicheau D.

Transpl Int. 2019 May;32(5):481-492. doi: 10.1111/tri.13392. Epub 2019 Jan 11.

PMID:
30565748
6.

Benefits of kidney transplantation for a national cohort of patients aged 70 years and older starting renal replacement therapy.

Legeai C, Andrianasolo RM, Moranne O, Snanoudj R, Hourmant M, Bauwens M, Soares J, Jacquelinet C, Couchoud C, Macher MA.

Am J Transplant. 2018 Nov;18(11):2695-2707. doi: 10.1111/ajt.15110. Epub 2018 Oct 18.

PMID:
30203618
7.

Response to: "Renal allograft histology at 10 years after transplantation in the tacrolimus era: Evidence of pervasive chronic injury".

Snanoudj R, Legendre C.

Am J Transplant. 2018 May;18(5):1292. doi: 10.1111/ajt.14612. Epub 2017 Dec 28. No abstract available.

8.

Midterm Outcomes of 12 Renal Transplant Recipients Treated With Eculizumab to Prevent Atypical Hemolytic Syndrome Recurrence.

Levi C, Frémeaux-Bacchi V, Zuber J, Rabant M, Devriese M, Snanoudj R, Scemla A, Amrouche L, Mejean A, Legendre C, Sberro-Soussan R.

Transplantation. 2017 Dec;101(12):2924-2930. doi: 10.1097/TP.0000000000001909.

PMID:
28858176
9.

Long-term Outcomes of Kidney Transplantation in Patients With High Levels of Preformed DSA: The Necker High-Risk Transplant Program.

Amrouche L, Aubert O, Suberbielle C, Rabant M, Van Huyen JD, Martinez F, Sberro-Soussan R, Scemla A, Tinel C, Snanoudj R, Zuber J, Cavalcanti R, Timsit MO, Lamhaut L, Anglicheau D, Loupy A, Legendre C.

Transplantation. 2017 Oct;101(10):2440-2448. doi: 10.1097/TP.0000000000001650.

PMID:
28114171
10.

Efficacy and safety of febuxostat in 73 gouty patients with stage 4/5 chronic kidney disease: A retrospective study of 10 centers.

Juge PA, Truchetet ME, Pillebout E, Ottaviani S, Vigneau C, Loustau C, Cornec D, Pascart T, Snanoudj R, Bailly F, Cornec-Le Gall E, Schaeverbeke T, Saraux A, Dieudé P, Flipo RM, Richette P, Lioté F, Bardin T, Chalès G, Ea HK.

Joint Bone Spine. 2017 Oct;84(5):595-598. doi: 10.1016/j.jbspin.2016.09.020. Epub 2016 Nov 4.

PMID:
27825577
11.

Prognosis of Invasive Aspergillosis in Kidney Transplant Recipients: A Case-Control Study.

Desbois AC, Poiree S, Snanoudj R, Bougnoux ME, Sberro-Soussan R, Lanternier F, Legendre C, Lortholary O, Scemla A.

Transplant Direct. 2016 Jul 1;2(8):e90. eCollection 2016 Aug.

12.

Dual Kidney Transplantation: Is It Worth It?

Snanoudj R, Timsit MO, Rabant M, Tinel C, Lazareth H, Lamhaut L, Martinez F, Legendre C.

Transplantation. 2017 Mar;101(3):488-497. doi: 10.1097/TP.0000000000001508. Review.

PMID:
27748703
13.

[New aspects of HLA compatibility in organ transplantation].

Snanoudj R, Legendre C.

Nephrol Ther. 2016 Apr;12 Suppl 1:S125-30. doi: 10.1016/j.nephro.2016.01.006. Epub 2016 Mar 8. French.

PMID:
26968475
14.

Early Low Urinary CXCL9 and CXCL10 Might Predict Immunological Quiescence in Clinically and Histologically Stable Kidney Recipients.

Rabant M, Amrouche L, Morin L, Bonifay R, Lebreton X, Aouni L, Benon A, Sauvaget V, Le Vaillant L, Aulagnon F, Sberro R, Snanoudj R, Mejean A, Legendre C, Terzi F, Anglicheau D.

Am J Transplant. 2016 Jun;16(6):1868-81. doi: 10.1111/ajt.13677. Epub 2016 Mar 10.

15.

Long-term CD4 lymphopenia is associated with accelerated decline of kidney allograft function.

Luque Y, Jamme M, Rabant M, DeWolf S, Noël LH, Thervet E, Chatenoud L, Snanoudj R, Anglicheau D, Legendre C, Candon S, Zuber J.

Nephrol Dial Transplant. 2016 Mar;31(3):487-95. doi: 10.1093/ndt/gfv362. Epub 2015 Oct 22.

PMID:
26492923
16.

Eight-year results of the Spiesser study, a randomized trial comparing de novo sirolimus and cyclosporine in renal transplantation.

Gatault P, Bertrand D, Büchler M, Colosio C, Hurault de Ligny B, Weestel PF, Rerolle JP, Thierry A, Sayegh J, Moulin B, Snanoudj R, Rivalan J, Heng AE, Sautenet B, Lebranchu Y.

Transpl Int. 2016 Jan;29(1):41-50. doi: 10.1111/tri.12656.

17.

Excellent long-term outcome of renal transplantation in cystinosis patients.

Cohen C, Charbit M, Chadefaux-Vekemans B, Giral M, Garrigue V, Kessler M, Antoine C, Snanoudj R, Niaudet P, Kreis H, Legendre C, Servais A.

Orphanet J Rare Dis. 2015 Jul 25;10:90. doi: 10.1186/s13023-015-0307-9.

18.

Immunological risks of minimization strategies.

Snanoudj R, Tinel C, Legendre C.

Transpl Int. 2015 Aug;28(8):901-10. doi: 10.1111/tri.12570. Epub 2015 Apr 9. Review.

19.

Dramatic improvement of severe cryptococcosis-induced immune reconstitution syndrome with adalimumab in a renal transplant recipient.

Scemla A, Gerber S, Duquesne A, Parize P, Martinez F, Anglicheau D, Snanoudj R, Zuber M, Bougnoux ME, Legendre C, Lortholary O.

Am J Transplant. 2015 Feb;15(2):560-4. doi: 10.1111/ajt.13002. Epub 2015 Jan 21.

20.

Restricted specificity of peripheral alloreactive memory B cells in HLA-sensitized patients awaiting a kidney transplant.

Snanoudj R, Claas FH, Heidt S, Legendre C, Chatenoud L, Candon S.

Kidney Int. 2015 Jun;87(6):1230-40. doi: 10.1038/ki.2014.390. Epub 2015 Jan 7.

21.

[Current aspects of acute humoral rejection].

Legendre C, Loupy A, Rabant M, Aubert O, Rabaté C, Delville M, Tinel C, Amrouche L, Martinez F, Snanoudj R, Bererhi L, Scemla A, Sberro-Soussan R, Duong JP, Suberbielle C, Anglicheau D.

Nephrol Ther. 2014 Nov;10(6):479-83. doi: 10.1016/j.nephro.2014.09.001. Epub 2014 Oct 16. Review. French.

PMID:
25440942
22.

Inhibition of the mTORC pathway in the antiphospholipid syndrome.

Canaud G, Bienaimé F, Tabarin F, Bataillon G, Seilhean D, Noël LH, Dragon-Durey MA, Snanoudj R, Friedlander G, Halbwachs-Mecarelli L, Legendre C, Terzi F.

N Engl J Med. 2014 Jul 24;371(4):303-12. doi: 10.1056/NEJMoa1312890.

23.

Severe infections requiring intensive care unit admission in kidney transplant recipients: impact on graft outcome.

Bige N, Zafrani L, Lambert J, Peraldi MN, Snanoudj R, Reuter D, Legendre C, Chevret S, Lemiale V, Schlemmer B, Azoulay E, Canet E.

Transpl Infect Dis. 2014 Aug;16(4):588-96. doi: 10.1111/tid.12249. Epub 2014 Jun 26.

PMID:
24966154
24.

Peripheral B-cell phenotype and BAFF levels are associated with HLA immunization in patients awaiting kidney transplantation.

Snanoudj R, Candon S, Roelen DL, Jais JP, Claas FH, Legendre C, Chatenoud L.

Transplantation. 2014 May 15;97(9):917-24. doi: 10.1097/01.TP.0000438211.34842.5e.

PMID:
24827764
25.

Risk of antibody-mediated rejection in kidney transplant recipients with anti-HLA-C donor-specific antibodies.

Aubert O, Bories MC, Suberbielle C, Snanoudj R, Anglicheau D, Rabant M, Martinez F, Scemla A, Legendre C, Sberro-Soussan R.

Am J Transplant. 2014 Jun;14(6):1439-45. doi: 10.1111/ajt.12709. Epub 2014 May 7.

26.

Successful outcome of a corticodependent henoch-schönlein purpura adult with rituximab.

Pindi Sala T, Michot JM, Snanoudj R, Dollat M, Estève E, Marie B, Taoufik Y, Delfraissy JF, Lazure T, Lambotte O.

Case Rep Med. 2014;2014:619218. doi: 10.1155/2014/619218. Epub 2014 Apr 1.

27.

T-cell-depleting antibodies and risk of cancer after transplantation.

Snanoudj R, Legendre C.

Transplantation. 2014 Apr 27;97(8):808-9. doi: 10.1097/01.TP.0000442780.88287.e7. No abstract available.

PMID:
24670299
28.

Outcome of kidney transplantations performed with preformed donor-specific antibodies of unknown etiology.

Sicard A, Amrouche L, Suberbielle C, Carmagnat M, Candon S, Thervet E, Delahousse M, Legendre C, Chatenoud L, Snanoudj R.

Am J Transplant. 2014 Jan;14(1):193-201. doi: 10.1111/ajt.12512. Epub 2013 Nov 13.

29.

[Renal transplantation: ethical issues].

Mamzer-Bruneel MF, Laforêt EG, Kreis H, Thervet É, Martinez F, Snanoudj R, Hervé C, Legendre C.

Nephrol Ther. 2012 Dec;8(7):547-56. doi: 10.1016/j.nephro.2012.10.001. Epub 2012 Nov 16. French.

PMID:
23168353
30.

Late-onset post-transplantation lymphoproliferative disorders after kidney transplantation: a monocentric study over three decades.

Michonneau D, Suarez F, Lambert J, Adam J, Brousse N, Canioni D, Anglicheau D, Martinez F, Snanoudj R, Legendre C, Hermine O, Mamzer-Bruneel MF.

Nephrol Dial Transplant. 2013 Feb;28(2):471-8. doi: 10.1093/ndt/gfs476. Epub 2012 Nov 4.

PMID:
23129824
31.

Home and office blood pressure monitoring in renal transplant recipients.

Sberro-Soussan R, Rabant M, Snanoudj R, Zuber J, Bererhi L, Mamzer MF, Legendre C, Thervet E.

J Transplant. 2012;2012:702316. doi: 10.1155/2012/702316. Epub 2012 Apr 17.

32.

Five-year results of a randomized trial comparing de novo sirolimus and cyclosporine in renal transplantation: the SPIESSER study.

Lebranchu Y, Snanoudj R, Toupance O, Weestel PF, Hurault de Ligny B, Buchler M, Rerolle JP, Thierry A, Moulin B, Subra JF, Deteix P, Le Pogamp P, Finzi L, Etienne I.

Am J Transplant. 2012 Jul;12(7):1801-10. doi: 10.1111/j.1600-6143.2012.04036.x. Epub 2012 Apr 5.

33.

Specificity of histological markers of long-term CNI nephrotoxicity in kidney-transplant recipients under low-dose cyclosporine therapy.

Snanoudj R, Royal V, Elie C, Rabant M, Girardin C, Morelon E, Kreis H, Fournet JC, Noël LH, Legendre C.

Am J Transplant. 2011 Dec;11(12):2635-46. doi: 10.1111/j.1600-6143.2011.03718.x. Epub 2011 Aug 30.

34.

Impact of norovirus/sapovirus-related diarrhea in renal transplant recipients hospitalized for diarrhea.

Roos-Weil D, Ambert-Balay K, Lanternier F, Mamzer-Bruneel MF, Nochy D, Pothier P, Avettand-Fenoel V, Anglicheau D, Snanoudj R, Bererhi L, Thervet E, Lecuit M, Legendre C, Lortholary O, Zuber J.

Transplantation. 2011 Jul 15;92(1):61-9. doi: 10.1097/TP.0b013e31821c9392.

PMID:
21555974
35.

[Immunosuppressive treatments: mechanisms of action and clinical use].

Thervet E, Zuber J, Sberro R, Canaud G, Anglicheau D, Snanoudj R, Mamzer-Bruneel MF, Martinez F, Legendre C.

Nephrol Ther. 2011 Dec;7(7):566-81. doi: 10.1016/j.nephro.2010.12.008. Epub 2011 Jan 26. French.

PMID:
21273149
36.

Co-stimulation blockade as a new strategy in kidney transplantation: benefits and limits.

Snanoudj R, Zuber J, Legendre C.

Drugs. 2010 Nov 12;70(16):2121-31. doi: 10.2165/11538140-000000000-00000. Review.

PMID:
20964456
37.

Targeting B cells in sensitized kidney transplant patients: state of the art and future perspectives.

Snanoudj R, Candon S, Legendre C.

Curr Opin Organ Transplant. 2010 Dec;15(6):709-15. doi: 10.1097/MOT.0b013e3283402cf4. Review.

PMID:
20930637
38.

Single graft loss in dual renal transplant recipients: impact of graft placement on recipient outcomes.

Timsit MO, Rabant M, Snanoudj R, Cohen D, Salin A, Malek S, Rouach Y, Kreis H, Legendre C, Mejean A.

Transpl Int. 2011 Jan;24(1):51-7. doi: 10.1111/j.1432-2277.2010.01145.x.

39.

[Nephrotoxicity of calcineurin inhibitors: presentation, diagnostic problems and risk factors].

Snanoudj R, Rabant M, Royal V, Pallet N, Noël LH, Legendre C.

Nephrol Ther. 2009 Dec;5 Suppl 6:S365-70. doi: 10.1016/S1769-7255(09)73427-3. French.

PMID:
20129447
40.

Bortezomib as the sole post-renal transplantation desensitization agent does not decrease donor-specific anti-HLA antibodies.

Sberro-Soussan R, Zuber J, Suberbielle-Boissel C, Candon S, Martinez F, Snanoudj R, Rabant M, Pallet N, Nochy D, Anglicheau D, Leruez M, Loupy A, Thervet E, Hermine O, Legendre C.

Am J Transplant. 2010 Mar;10(3):681-6. doi: 10.1111/j.1600-6143.2009.02968.x. Epub 2010 Feb 1.

41.

Kidney transplantation at Necker Hospital: the most recent 5-year period (2004-2009).

Legendre Ch, Kreis H, Martinez F, Snanoudj R, Mamzer MF, Sberro R, Bererhi L, Anglicheau D, Zuber J, Loupy A, Thervet E, Pallet N, Sartorius A, Bertrand D, Canaud G, Noël LH, Rabant M, Timsit MO, Méjean A.

Clin Transpl. 2010:127-32.

PMID:
21696035
42.

Donor-estimated GFR as an appropriate criterion for allocation of ECD kidneys into single or dual kidney transplantation.

Snanoudj R, Rabant M, Timsit MO, Karras A, Savoye E, Tricot L, Loupy A, Hiesse C, Zuber J, Kreis H, Martinez F, Thervet E, Méjean A, Lebret T, Legendre C, Delahousse M.

Am J Transplant. 2009 Nov;9(11):2542-51. doi: 10.1111/j.1600-6143.2009.02797.x.

43.

Recurrence of nephrotic syndrome after transplantation in a mixed population of children and adults: course of glomerular lesions and value of the Columbia classification of histological variants of focal and segmental glomerulosclerosis (FSGS).

Canaud G, Dion D, Zuber J, Gubler MC, Sberro R, Thervet E, Snanoudj R, Charbit M, Salomon R, Martinez F, Legendre C, Noel LH, Niaudet P.

Nephrol Dial Transplant. 2010 Apr;25(4):1321-8. doi: 10.1093/ndt/gfp500. Epub 2009 Sep 22.

PMID:
19773419
44.

FOXP3-enriched infiltrates associated with better outcome in renal allografts with inflamed fibrosis.

Zuber J, Brodin-Sartorius A, Lapidus N, Patey N, Tosolini M, Candon S, Rabant M, Snanoudj R, Panterne C, Thervet E, Legendre C, Chatenoud L.

Nephrol Dial Transplant. 2009 Dec;24(12):3847-54. doi: 10.1093/ndt/gfp435. Epub 2009 Sep 3.

PMID:
19729462
45.

Incidence, risk factors and clinical consequences of neutropenia following kidney transplantation: a retrospective study.

Zafrani L, Truffaut L, Kreis H, Etienne D, Rafat C, Lechaton S, Anglicheau D, Zuber J, Ciroldi M, Thervet E, Snanoudj R, Mamzer MF, Martinez F, Timsit MO, Bergougnoux L, Legendre C.

Am J Transplant. 2009 Aug;9(8):1816-25. doi: 10.1111/j.1600-6143.2009.02699.x. Epub 2009 Jun 16.

46.

Intensive and prolonged treatment of focal and segmental glomerulosclerosis recurrence in adult kidney transplant recipients: a pilot study.

Canaud G, Zuber J, Sberro R, Royale V, Anglicheau D, Snanoudj R, Gaha K, Thervet E, Lefrère F, Cavazzana-Calvo M, Noël LH, Méjean A, Legendre Ch, Martinez F.

Am J Transplant. 2009 May;9(5):1081-6. doi: 10.1111/j.1600-6143.2009.02580.x. Epub 2009 Mar 16.

47.

Early conservative intervention for candida contamination of preservative fluid without allograft nephrectomy.

Canaud G, Timsit MO, Zuber J, Bougnoux ME, Méjean A, Thervet E, Snanoudj R, Sberro R, Martinez F, Legendre C, Mamzer-Bruneel MF.

Nephrol Dial Transplant. 2009 Apr;24(4):1325-7. doi: 10.1093/ndt/gfn622. Epub 2008 Nov 11.

PMID:
19004850
48.

[Screening biopsies in kidney transplantation: from subclinical acute rejection to chronic allograft lesions].

Snanoudj R, Martinez F, Sberro Soussan R, Thervet E, Legendre C.

Nephrol Ther. 2008 Oct;4 Suppl 3:S192-9. doi: 10.1016/S1769-7255(08)74234-2. Review. French.

PMID:
19000886
49.

High-dosage intravenous immunoglobulin-associated macrovacuoles are associated with chronic tubulointerstitial lesion worsening in renal transplant recipients.

Bollée G, Anglicheau D, Loupy A, Zuber J, Patey N, Mac Gregor D, Martinez F, Mamzer-Bruneel MF, Snanoudj R, Thervet E, Legendre C, Noël LH.

Clin J Am Soc Nephrol. 2008 Sep;3(5):1461-8. doi: 10.2215/CJN.00500108. Epub 2008 Jun 4.

50.

Sirolimus may reduce fertility in male renal transplant recipients.

Zuber J, Anglicheau D, Elie C, Bererhi L, Timsit MO, Mamzer-Bruneel MF, Ciroldi M, Martinez F, Snanoudj R, Hiesse C, Kreis H, Eustache F, Laborde K, Thervet E, Legendre C.

Am J Transplant. 2008 Jul;8(7):1471-9. doi: 10.1111/j.1600-6143.2008.02267.x.

Supplemental Content

Loading ...
Support Center